Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates

Journal of Drug Targeting
Hans WellhönerJacob Hochman

Abstract

Multi-drug resistance (MDR) is still a major cause of the eventual failure of chemotherapy in cancer treatment. Different approaches have been taken to render these cells drug sensitive. Here, we attempted sensitizing drug-resistant cells from within, using a translocating immune conjugate approach. To that effect, a monoclonal antibody, C219, directed against the intracellular ATP-binding site of the membrane-anchored MDR transporter ABCB1 [P-glycoprotein (P-gp), MDR1], was conjugated to human immunodeficiency virus [HIV(37-72)Tat] translocator peptide through a disulfide bridge. Fluorescence-labelled IgG-Tat conjugates accumulated in drug resistant Chinese hamster ovary (CHO) cells within less than 20 min. Preincubation with C219-S-S-(37-72)Tat conjugate augmented calcein accumulation in drug-resistant CHO and mouse lymphoma cells, indicating reduction in ABCB1 transporter activity. A thioether conjugate C219-S-(37-72)Tat was ineffective, as were disulfide and thioether conjugates of an irrelevant antibody. Furthermore, in the presence of C219-S-S-(37-72)Tat, drug resistant cells were sensitized to colchicine and doxorubicin. Taken together, these findings demonstrate, as proof of principle, a novel approach for the reversal ...Continue Reading

References

Jul 1, 1977·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·I T Young
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E B Mechetner, I B Roninson
Sep 1, 1991·Journal of Cellular Physiology·E GeorgesV Ling
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E GeorgesV Ling
Oct 1, 1984·The Journal of Cell Biology·J HochmanE Okon
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H GalskiJ Hochman
May 11, 1994·Biochimica Et Biophysica Acta·Z HollóB Sarkadi
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·K J ScanlonM Kashani-Sabet
Jul 29, 1996·International Journal of Cancer. Journal International Du Cancer·M NaitoT Tsuruo
Jan 13, 1997·Biochemical and Biophysical Research Communications·N KokubuT Watanabe
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·J M van Den ElsenD R Rose
Apr 3, 2001·International Journal of Cancer. Journal International Du Cancer·Y HeikeD T Curiel
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Oct 11, 2003·Biochemical and Biophysical Research Communications·Masayasu MieEiry Kobatake
Oct 25, 2003·Oncogene·Suresh V AmbudkarMichael M Gottesman
Oct 31, 2003·Journal of Medicinal Chemistry·Jacques Robert, Christian Jarry
Mar 5, 2004·International Journal of Cancer. Journal International Du Cancer·Maya Haus-CohenYoram Reiter
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Verena MaternaHermann Lage
Sep 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ulrike SteinHermann Lage
May 16, 2009·Current Cancer Drug Targets·Katalin GodaGábor Szabó

❮ Previous
Next ❯

Citations

Oct 19, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jian-Ye ZhangHu-Biao Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.